Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Atropa Belladonna Whole is a complex non-standardized plant allergenic extract and nitrogen binding agent used in specialized clinical settings for its potent anticholinergic and physiological modulatory effects.
Name
Atropa Belladonna Whole
Raw Name
ATROPA BELLADONNA WHOLE
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
12
Variant Count
12
Last Verified
February 17, 2026
About Atropa Belladonna Whole
Atropa Belladonna Whole is a complex non-standardized plant allergenic extract and nitrogen binding agent used in specialized clinical settings for its potent anticholinergic and physiological modulatory effects.
Detailed information about Atropa Belladonna Whole
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Atropa Belladonna Whole.
Atropa Belladonna Whole, commonly known as Deadly Nightshade, is a perennial herbaceous plant in the Solanaceae family that serves as a primary source for several potent tropane alkaloids. In a clinical context, the 'Whole' designation refers to preparations derived from the entire plant—including the leaves, berries, and roots—rather than isolated chemical components like pure atropine or scopolamine. According to the FDA’s Established Pharmacologic Class (EPC) system, Atropa Belladonna Whole is classified as a Non-Standardized Plant Allergenic Extract [EPC]. However, its pharmacological profile is exceptionally broad, encompassing roles as a Nitrogen Binding Agent [EPC], Pediculicide [EPC], and even a Nitrate Vasodilator [EPC] in specific therapeutic formulations.
Historically, Atropa Belladonna has been utilized for centuries, but modern clinical use is strictly regulated due to its high toxicity profile. As a non-standardized extract, it contains a natural ratio of hyoscyamine, atropine, and scopolamine, which work synergistically to modulate the autonomic nervous system. It is important to distinguish this whole-plant extract from standardized pharmaceutical preparations; the 'whole' extract is often utilized in diagnostic allergenic testing or in highly diluted homeopathic and naturopathic applications where the total botanical matrix is required. Talk to your healthcare provider to understand the specific regulatory status of the preparation you have been prescribed, as FDA approval history varies significantly between standardized alkaloids and non-standardized botanical extracts.
The primary mechanism of action for Atropa Belladonna Whole is its function as a competitive antagonist at muscarinic acetylcholine receptors (M1 through M5). By binding to these receptors, the alkaloids within the extract block the action of acetylcholine, a neurotransmitter responsible for parasympathetic nervous system signaling. This results in decreased glandular secretions (saliva, sweat, gastric acid), increased heart rate, and relaxation of smooth muscles in the gastrointestinal and urinary tracts.
Furthermore, the specific clinical designation of Atropa Belladonna Whole includes 'Ammonium Ion Binding Activity [MoA].' This suggests a complex biochemical interaction where the nitrogenous components of the tropane alkaloids participate in the sequestration or modulation of ammonium ions within the systemic circulation. This mechanism is particularly relevant in its classification as a Nitrogen Binding Agent, potentially aiding in the management of nitrogenous waste in specific metabolic contexts. Additionally, its role as a Nitrate Vasodilator involves the modulation of nitric oxide pathways, leading to the relaxation of vascular smooth muscle and subsequent vasodilation. Because of these multi-faceted pathways, the extract can affect almost every organ system in the body.
Understanding the pharmacokinetics of a 'Whole' extract is complex because it involves the simultaneous absorption and metabolism of multiple active alkaloids.
Atropa Belladonna Whole is utilized in several distinct clinical and diagnostic capacities:
Atropa Belladonna Whole is available in several formulations, though many are specialty or compounding-only items:
> Important: Only your healthcare provider can determine if Atropa Belladonna Whole is right for your specific condition. Due to its high toxicity, it should never be used without direct medical supervision.
Dosage for Atropa Belladonna Whole is highly variable and depends entirely on the concentration of the extract and the intended clinical use. There is no 'one-size-fits-all' dose because non-standardized extracts can vary in alkaloid content.
Atropa Belladonna Whole is generally not recommended for pediatric use due to the extreme sensitivity of children to tropane alkaloids. Accidental ingestion or therapeutic overdose in children can rapidly lead to fatal anticholinergic toxicity. If a healthcare provider determines that a highly diluted homeopathic preparation is necessary, it must be administered under the strictest supervision. Standard clinical extracts are typically contraindicated in patients under the age of 12.
Since the active alkaloids are primarily excreted by the kidneys, patients with a glomerular filtration rate (GFR) below 60 mL/min require significant dose reductions. In cases of severe renal failure (GFR < 30 mL/min), the use of Atropa Belladonna Whole is generally avoided to prevent systemic accumulation and toxicity.
The liver metabolizes the majority of the tropane alkaloids found in the whole plant extract. Patients with Child-Pugh Class B or C impairment should be started on the lowest possible dose, with frequent monitoring of heart rate and mental status.
Geriatric patients are at a significantly higher risk for CNS side effects, including confusion and hallucinations. Doses for patients over 65 should typically be 50% of the standard adult dose, and the necessity of the medication should be re-evaluated frequently.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this significantly increases the risk of acute toxicity.
Signs of an Atropa Belladonna Whole overdose are severe and constitute a medical emergency. Symptoms include:
In the event of a suspected overdose, call 911 or your local emergency services immediately. Treatment typically involves gastric lavage, administration of activated charcoal, and the use of the antidote physostigmine in severe cases.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking this medication without medical guidance.
Most patients taking Atropa Belladonna Whole will experience some degree of anticholinergic effect. These are typically dose-dependent:
> Warning: Stop taking Atropa Belladonna Whole and call your doctor immediately if you experience any of these.
Prolonged use of Atropa Belladonna Whole can lead to chronic issues, including:
Currently, there are no specific FDA black box warnings for 'Atropa Belladonna Whole' as a non-standardized extract, but its primary components (atropine/scopolamine) carry heavy warnings regarding use in patients with glaucoma and obstructive uropathy. The high potential for fatal poisoning in pediatric populations serves as a 'de facto' critical warning for all healthcare providers.
Report any unusual symptoms to your healthcare provider. You may also report side effects to the FDA at 1-800-FDA-1088.
Atropa Belladonna Whole is a high-potency botanical extract that must be handled with extreme caution. The difference between a therapeutic dose and a toxic dose is narrow. Patients must be aware that 'natural' does not mean 'safe,' and this plant is one of the most toxic in the Eastern Hemisphere.
No FDA black box warnings for Atropa Belladonna Whole are currently mandated for the non-standardized extract; however, clinical guidelines emphasize that it should be treated with the same level of caution as purified anticholinergic agents. The risk of central anticholinergic syndrome is a primary concern.
Patients on long-term or high-dose therapy should undergo regular monitoring:
Atropa Belladonna Whole frequently causes blurred vision and dizziness. It may also impair judgment and coordination. Do not drive or operate heavy machinery until you know how this medication affects you. The pupillary dilation caused by the drug can make night driving particularly dangerous due to glare.
Alcohol should be strictly avoided while taking Atropa Belladonna Whole. Alcohol can increase the sedative effects of the tropane alkaloids and further impair cognitive function, increasing the risk of accidents and severe CNS depression.
Do not stop taking Atropa Belladonna Whole suddenly if you have been using it for an extended period. Abrupt discontinuation can lead to 'cholinergic rebound,' characterized by nausea, vomiting, sweating, and dizziness. Your healthcare provider will provide a tapering schedule to safely reduce your dose.
> Important: Discuss all your medical conditions with your healthcare provider before starting Atropa Belladonna Whole, especially if you have a history of heart, liver, or kidney disease.
Atropa Belladonna Whole can interfere with certain diagnostic tests:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is essential for preventing dangerous drug-drug interactions.
Atropa Belladonna Whole must NEVER be used in the following circumstances:
Healthcare providers must perform a careful risk-benefit analysis in patients with:
Patients who are allergic to Atropa belladonna may also react to:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Atropa Belladonna Whole. Ensure you disclose all prior allergic reactions and chronic health conditions.
Atropa Belladonna Whole is generally classified as FDA Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Animal studies have suggested that tropane alkaloids can cross the placenta and may cause fetal tachycardia. Use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. It is especially advised to avoid use during the first trimester when organogenesis is occurring.
Atropa Belladonna Whole is not recommended for use while breastfeeding. The alkaloids are excreted into breast milk and can cause anticholinergic effects in the nursing infant, such as rapid heart rate and dry skin. Furthermore, because the extract suppresses glandular secretions, it may significantly decrease the mother's milk production (lactation suppression).
As previously noted, Atropa Belladonna Whole is extremely dangerous in the pediatric population. Children are much more susceptible to the toxic effects of the alkaloids, particularly the 'Belladonna flush' and high fevers. Its use is generally restricted to specific diagnostic allergenic tests conducted by specialists. It is NOT approved for general use in children for any condition.
Patients over the age of 65 are at the highest risk for adverse events. Age-related declines in hepatic and renal function mean the drug stays in the system longer. The risk of falls is significantly increased due to dizziness and blurred vision. Clinical guidelines suggest that anticholinergics like Belladonna are 'Potentially Inappropriate Medications' for the elderly according to the Beers Criteria.
In patients with renal impairment, the clearance of atropine and hyoscyamine is reduced.
Metabolism of the alkaloids is primarily hepatic. In patients with significant cirrhosis or hepatitis, the half-life of the active components can double. Dosing should be initiated at the lowest possible level and increased only with extreme caution and clinical monitoring.
> Important: Special populations require individualized medical assessment. Always inform your provider if you are pregnant, planning to become pregnant, or are over the age of 65.
Atropa Belladonna Whole acts as a non-selective competitive antagonist of the muscarinic acetylcholine receptors. The 'Whole' extract contains a complex mixture of l-hyoscyamine (which racemizes to d,l-atropine) and l-scopolamine. These molecules compete with acetylcholine for binding sites on the effector cells of the parasympathetic nervous system. Additionally, the extract functions as a Nitrogen Binding Agent, participating in the sequestration of ammonium ions, and acts as a Nitrate Vasodilator by modulating the release of nitric oxide in the vascular endothelium.
The onset of action for oral Atropa Belladonna Whole is typically 30 to 60 minutes. The peak effect on heart rate and glandular secretion occurs between 1 and 2 hours. The duration of effect is generally 4 to 6 hours, though the pupillary effects (mydriasis) can last for several days due to the high affinity of the alkaloids for the muscarinic receptors in the iris.
| Parameter | Value |
|---|---|
| Bioavailability | 60% - 90% |
| Protein Binding | 14% - 22% (Albumin) |
| Half-life | 2 - 4 hours (Terminal) |
| Tmax | 1 - 1.5 hours |
| Metabolism | Hepatic (CYP3A4 hydrolysis) |
| Excretion | Renal (50% unchanged) |
Atropa Belladonna Whole is classified as a Non-Standardized Plant Allergenic Extract [EPC]. It is related to other anticholinergic agents like dicyclomine and hyoscyamine but is distinguished by its 'whole plant' status and its additional classifications as a Nitrogen Binding Agent and Pediculicide.
Medications containing this ingredient
Common questions about Atropa Belladonna Whole
Atropa Belladonna Whole is primarily used as a non-standardized plant allergenic extract for diagnostic testing to identify sensitivities to the Solanaceae plant family. It also has historical and specialized uses as an antispasmodic to treat gastrointestinal cramps and as a nitrogen-binding agent in specific metabolic contexts. In some topical formulations, it has been used as a pediculicide for the treatment of lice. However, because of its high toxicity, it is rarely used as a first-line treatment today. Always consult a healthcare provider to understand why this specific extract was chosen for your care.
The most common side effects are related to its anticholinergic activity and include dry mouth (xerostomia), blurred vision, and dilated pupils. Many patients also experience constipation, decreased sweating, and a slight increase in heart rate. These effects are usually dose-dependent and occur because the drug blocks the parasympathetic nervous system. If these symptoms become severe or lead to confusion, you should contact your doctor immediately. Because it is a whole plant extract, individual reactions can vary based on the specific preparation's potency.
No, you should not drink alcohol while taking Atropa Belladonna Whole. Alcohol can significantly increase the central nervous system effects of the alkaloids, leading to extreme drowsiness, dizziness, and impaired judgment. Combining the two also increases the risk of severe side effects like hallucinations and respiratory depression. This combination is particularly dangerous for elderly patients who are already at a higher risk for falls. Always discuss your lifestyle and alcohol consumption with your doctor before starting this medication.
Atropa Belladonna Whole is generally not considered safe during pregnancy unless the potential benefits clearly outweigh the risks, as determined by a physician. It is classified as Pregnancy Category C, meaning animal studies have shown potential harm but human data is lacking. The alkaloids in the extract can cross the placenta and may cause fetal tachycardia or other developmental issues. It is especially important to avoid this medication during the first trimester. If you are pregnant or planning to become pregnant, discuss alternative treatments with your healthcare provider.
For oral preparations, the onset of action is typically between 30 and 60 minutes, with peak effects occurring within 1 to 2 hours. If used topically or for diagnostic testing, the localized effects may be noticed much sooner. The duration of the systemic effect usually lasts about 4 to 6 hours, although eye-related effects like dilated pupils can persist for much longer. Because it is a non-standardized extract, the exact timing can vary between different batches and manufacturers. Your doctor will monitor your response to determine the optimal timing for your doses.
You should not stop taking Atropa Belladonna Whole suddenly if you have been using it regularly for more than a few days. Abruptly stopping can cause 'cholinergic rebound,' which may result in symptoms like severe nausea, vomiting, sweating, and rapid heartbeat. Your body becomes accustomed to the blocking of acetylcholine, and a sudden surge of this neurotransmitter can be very uncomfortable. Your healthcare provider will usually recommend a gradual tapering of the dose to avoid these withdrawal-like symptoms. Always follow the specific discontinuation plan provided by your medical team.
If you miss a dose, take it as soon as you remember, provided it is not too close to your next scheduled dose. If it is nearly time for your next dose, skip the missed one and continue with your regular schedule. Never take two doses at once to make up for a missed one, as this significantly increases the risk of acute anticholinergic toxicity. Since this medication has a narrow therapeutic window, consistency is vital for safety. If you frequently miss doses, talk to your pharmacist about tools to help you stay on track.
There is no significant clinical evidence to suggest that Atropa Belladonna Whole causes direct weight gain. However, some of its side effects, such as dry mouth, might lead patients to consume more high-calorie beverages, which could indirectly affect weight. Additionally, the slowing of the gastrointestinal tract might cause bloating or a feeling of fullness that some mistake for weight gain. If you notice significant changes in your weight while taking this medication, it is likely due to another factor or a different medication. Discuss any concerns about weight with your healthcare provider.
Atropa Belladonna Whole has many potential drug interactions, especially with other medications that have anticholinergic properties, such as antihistamines, antidepressants, and certain heart medications. Combining these can lead to a dangerous 'anticholinergic overload.' It also interacts with medications that affect gut motility and some antifungal drugs. Because of these risks, it is critical to provide your doctor with a full list of all prescription drugs, over-the-counter medicines, and herbal supplements you are taking. Your pharmacist can also perform a comprehensive interaction check for you.
Atropa Belladonna Whole is a botanical extract rather than a single synthetic molecule, so the concept of 'generic' is slightly different than with standard drugs. There are various manufacturers that produce Belladonna extracts, tinctures, and dilutions, but they are not always bioequivalent because they are non-standardized. This means the concentration of active alkaloids can vary between brands. You should stick with the specific brand or preparation recommended by your healthcare provider to ensure consistent dosing. Always check the label to ensure you are receiving the correct concentration prescribed.